Addressing knowledge and attitude barriers to lung cancer screening: Development and evaluation of web-based decision aid

IF 4.5 2区 医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2024-11-21 DOI:10.1016/j.lungcan.2024.108031
Wonyoung Jung , In Young Cho , Keun Hye Jeon , Yohwan Yeo , Jongho Cho , Kyu-Won Jung , Kui Son Choi , Dong Wook Shin , Jungkwon Lee
{"title":"Addressing knowledge and attitude barriers to lung cancer screening: Development and evaluation of web-based decision aid","authors":"Wonyoung Jung ,&nbsp;In Young Cho ,&nbsp;Keun Hye Jeon ,&nbsp;Yohwan Yeo ,&nbsp;Jongho Cho ,&nbsp;Kyu-Won Jung ,&nbsp;Kui Son Choi ,&nbsp;Dong Wook Shin ,&nbsp;Jungkwon Lee","doi":"10.1016/j.lungcan.2024.108031","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Low-dose computed tomography screening reduces lung cancer and overall mortality, but the participation rate remains low. The objective of this study was to develop a decision aid (DA) that addresses the overabundance of healthcare options and barriers to participation in lung cancer screening (LCS) among the general population aged 40–79 years in Korea.</div></div><div><h3>Materials and Methods</h3><div>The DA was developed by following the International Patient Decision Aid Standards process. To evaluate the DA, participants aged 40–79 years were purposively sampled from four districts of the Seoul metropolitan area, with 25 individuals from each decade of the age range. Participants used the DA for LCS, and pre–post comparison was conducted. The primary outcome was a change in intention to undergo LCS after completing the DA. The secondary outcomes were changes in knowledge and attitude about LCS, decisional conflict, and the perceived usefulness of the DA.</div></div><div><h3>Results</h3><div>The DA prototype contained lung cancer risk assessment and decision-making components that addressed knowledge, risks, benefits, costs, and personal values. In a pilot study of 100 participants (mean age 59.0 [SD 11.1] years, 80 % male, 25 % of whom had undergone LCS), knowledge about LCS increased (mean [SD] score [out of 100] before vs. after: 68.3 [13.4] vs. 73.6 [18.0], p &lt; 0.001). A positive change in attitude was observed (p = 0.004), but the intention to screen remained consistent (70 % before vs. 72 % after; p = 0.650). Eighty-eight participants reported the lowest level of conflict in decision-making, and most reported that the DA was useful (mean [SD] score 78.8 [9.0] out of 100). 72 % reported that the DA facilitated self-decision-making, but 27 % felt the DA recommended LCS.</div></div><div><h3>Conclusions</h3><div>This study highlights the potential of a well-designed DA to enhance knowledge and attitudes about LCS, but those improvements did not translate to a significant change in screening intentions.</div></div>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"198 ","pages":"Article 108031"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500224005658","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Low-dose computed tomography screening reduces lung cancer and overall mortality, but the participation rate remains low. The objective of this study was to develop a decision aid (DA) that addresses the overabundance of healthcare options and barriers to participation in lung cancer screening (LCS) among the general population aged 40–79 years in Korea.

Materials and Methods

The DA was developed by following the International Patient Decision Aid Standards process. To evaluate the DA, participants aged 40–79 years were purposively sampled from four districts of the Seoul metropolitan area, with 25 individuals from each decade of the age range. Participants used the DA for LCS, and pre–post comparison was conducted. The primary outcome was a change in intention to undergo LCS after completing the DA. The secondary outcomes were changes in knowledge and attitude about LCS, decisional conflict, and the perceived usefulness of the DA.

Results

The DA prototype contained lung cancer risk assessment and decision-making components that addressed knowledge, risks, benefits, costs, and personal values. In a pilot study of 100 participants (mean age 59.0 [SD 11.1] years, 80 % male, 25 % of whom had undergone LCS), knowledge about LCS increased (mean [SD] score [out of 100] before vs. after: 68.3 [13.4] vs. 73.6 [18.0], p < 0.001). A positive change in attitude was observed (p = 0.004), but the intention to screen remained consistent (70 % before vs. 72 % after; p = 0.650). Eighty-eight participants reported the lowest level of conflict in decision-making, and most reported that the DA was useful (mean [SD] score 78.8 [9.0] out of 100). 72 % reported that the DA facilitated self-decision-making, but 27 % felt the DA recommended LCS.

Conclusions

This study highlights the potential of a well-designed DA to enhance knowledge and attitudes about LCS, but those improvements did not translate to a significant change in screening intentions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
消除肺癌筛查的知识和态度障碍:开发和评估基于网络的决策辅助工具
低剂量计算机断层扫描筛查可降低肺癌和总死亡率,但参与率仍然很低。本研究旨在开发一种决策辅助工具(DA),以解决韩国 40-79 岁普通人群中医疗保健选择过多和参与肺癌筛查(LCS)障碍的问题。为了评估该辅助工具,我们有目的地从首尔大都会区的四个地区抽取了 40-79 岁的参与者,每个年龄段各抽取 25 人。受试者使用 DA 进行 LCS,并进行了前后比较。主要结果是完成 DA 后进行 LCS 的意向变化。DA原型包含肺癌风险评估和决策部分,涉及知识、风险、益处、成本和个人价值观。在对 100 名参与者(平均年龄 59.0 [SD 11.1]岁,80% 为男性,其中 25% 接受过肺癌筛查)进行的试点研究中,他们对肺癌筛查的了解有所增加(筛查前与筛查后的平均[SD]得分[满分 100 分]对比为 68.3 [13.4] 分):68.3 [13.4] vs. 73.6 [18.0], p < 0.001)。观察到态度发生了积极变化(p = 0.004),但筛查意向保持一致(筛查前 70% 对筛查后 72%;p = 0.650)。有 88 名参与者报告说,决策过程中的冲突程度最低,大多数人报告说 DA 很有用(平均分 [SD] 为 78.8 [9.0],满分为 100 分)。72%的参与者表示DA促进了自我决策,但27%的参与者认为DA推荐了LCS。结论这项研究强调了设计良好的DA在提高对LCS的认识和态度方面的潜力,但这些改进并没有转化为筛查意向的显著变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lung Cancer
Lung Cancer 医学-呼吸系统
CiteScore
9.40
自引率
3.80%
发文量
407
审稿时长
25 days
期刊介绍: Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
期刊最新文献
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study Addressing knowledge and attitude barriers to lung cancer screening: Development and evaluation of web-based decision aid Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future care The molecular subtypes of small cell lung cancer defined by key transcription factors and their clinical significance Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1